Is D37.032 a billable ICD-10-CM code?

Yes. D37.032 is a billable, specific ICD-10-CM code and is valid for submission on a claim.

Where does D37.032 sit in the tabular list?

Neoplasms (C00-D49), in the block Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48).

What cannot be coded together with D37.032?

D37.032 carries Excludes1 notes, which means the conditions they list can never be coded together with it on the same encounter. Some are written on the categories above D37.032 (D37.0, D37) and apply to it just the same.

D37.032

D37.032 — Neoplasm of uncertain behavior of the submandibular salivary glands

Billable / specific codeICD-10-CM

D37.032 is a billable, specific ICD-10-CM code for neoplasm of uncertain behavior of the submandibular salivary glands. It is valid for submission on a claim.

Excludes1 inherited from the categories above D37.032

These are not written on D37.032, but they bind it: a note on a category applies to every code beneath it. Billing D37.032 with anything listed here is a denial.

Written on D37.0 — Neoplasm of uncertain behavior of lip, oral cavity and pharynx

neoplasm of uncertain behavior of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D38.0)
neoplasm of uncertain behavior of epiglottis NOS (D38.0)
neoplasm of uncertain behavior of skin of lip (D48.5)
neoplasm of uncertain behavior of suprahyoid portion of epiglottis (D38.0)

Written on D37 — Neoplasm of uncertain behavior of oral cavity and digestive organs

stromal tumors of uncertain behavior of digestive system (D48.1-)

Risk adjustment

D37.032 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.

Medicare coverage

D37.032 is named in 18 Medicare coverage policies — 18 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.

A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
A55717Billing and Coding: Lab: Flow Cytometry
A56462Billing and Coding: Erythropoiesis Stimulating Agents (ESA)

Code history

D37.032 has not changed since FY2024 — no addition, revision or deletion across the FY2024–FY2027 ICD-10-CM releases.

Related codes at this level

Codes that share D37.03. If D37.032 is not quite right, the correct code is usually one of these.

Questions about D37.032

Is D37.032 a billable ICD-10-CM code?: Yes. D37.032 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
Where does D37.032 sit in the tabular list?: Neoplasms (C00-D49), in the block Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48).
What cannot be coded together with D37.032?: D37.032 carries Excludes1 notes, which means the conditions they list can never be coded together with it on the same encounter. Some are written on the categories above D37.032 (D37.0, D37) and apply to it just the same.